Veeva Systems Inc. $VEEV Shares Acquired by Motley Fool Asset Management LLC

Key Points

• Motley Fool Asset Management increased its Veeva Systems stake by 364% in the third quarter, owning 11,220 shares valued at approximately $3.2 million. Institutional investors and hedge funds collectively own 88.2% of the company.
• Analysts maintain a positive outlook, with a consensus “Moderate Buy” rating and average price target of $293.21; recent targets ranged from $275 to $345.
• Veeva’s latest quarterly results exceeded expectations, with earnings of $2.35 per share and revenue of $927.96 million, up 17.6% year over year. Shares opened at $310.24, near their 52-week high, while insiders sold approximately $14.9 million of stock during the quarter.

Motley Fool Asset Management LLC increased its position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 364.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,220 shares of the technology company's stock after buying an additional 8,802 shares during the quarter. Motley Fool Asset Management LLC's holdings in Veeva Systems were worth $3,203,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Principal Financial Group Inc. raised its holdings in Veeva Systems by 7.0% in the 1st quarter. Principal Financial Group Inc. now owns 4,141,545 shares of the technology company's stock valued at $727,513,000 after acquiring an additional 271,252 shares in the last quarter. Swedbank AB grew its holdings in shares of Veeva Systems by 43.5% during the 1st quarter. Swedbank AB now owns 1,645,128 shares of the technology company's stock worth $288,983,000 after purchasing an additional 498,971 shares in the last quarter. Amundi grew its holdings in shares of Veeva Systems by 8.0% during the 1st quarter. Amundi now owns 992,977 shares of the technology company's stock worth $174,426,000 after purchasing an additional 73,510 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its holdings in shares of Veeva Systems by 203.0% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company's stock worth $160,427,000 after purchasing an additional 611,868 shares in the last quarter. Finally, Royal Bank of Canada increased its position in shares of Veeva Systems by 2.7% during the first quarter. Royal Bank of Canada now owns 870,281 shares of the technology company's stock valued at $152,873,000 after purchasing an additional 23,117 shares during the period. 88.20% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently commented on VEEV. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $330.00 target price on shares of Veeva Systems in a research report on Tuesday, September 8th. Morgan Stanley lifted their price target on shares of Veeva Systems from $215.00 to $275.00 and gave the stock an "equal weight" rating in a research note on Thursday, August 27th. Mizuho set a $345.00 price target on shares of Veeva Systems in a report on Thursday. Truist Financial increased their price objective on shares of Veeva Systems from $262.00 to $305.00 and gave the company a "buy" rating in a research note on Thursday, August 27th. Finally, Oppenheimer reaffirmed an "outperform" rating and set a $325.00 price objective on shares of Veeva Systems in a report on Thursday, October 15th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $293.21.

Veeva Systems Trading Down 2.4%

Shares of VEEV opened at $310.24 on Friday. Veeva Systems Inc. has a 1 year low of $148.05 and a 1 year high of $325.99. The stock has a 50 day simple moving average of $282.72 and a 200-day simple moving average of $209.39. The stock has a market cap of $50.23 billion, a PE ratio of 51.34, a PEG ratio of 1.36 and a beta of 0.93.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The business had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same quarter in the previous year, the firm earned $1.99 EPS. Veeva Systems's quarterly revenue was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, sell-side analysts forecast that Veeva Systems Inc. will post 6.70 EPS for the current fiscal year.

Insider Activity

In related news, EVP Daniel J. Rizzo sold 4,841 shares of Veeva Systems stock in a transaction dated Friday, October 2nd. The shares were sold at an average price of $276.51, for a total transaction of $1,338,584.91. Following the completion of the transaction, the executive vice president directly owned 7,665 shares of the company's stock, valued at $2,119,449.15. This trade represents a 38.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Priscilla Hung sold 750 shares of the business's stock in a transaction dated Wednesday, September 9th. The shares were sold at an average price of $261.04, for a total transaction of $195,780.00. Following the completion of the transaction, the director owned 3,242 shares in the company, valued at approximately $846,291.68. This trade represents a 18.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 56,789 shares of company stock worth $14,913,889 in the last quarter. 10.60% of the stock is owned by company insiders.

Veeva Systems News Summary

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: AI adoption remains a major growth catalyst. At its Commercial Summit Europe, Veeva highlighted AI-driven CRM, conversational tools, Commercial Cloud and Data Cloud innovations designed to improve healthcare-professional engagement, content approval and medical decision-making. Customer examples from AstraZeneca, Bristol Myers Squibb and Roche support the potential for broader adoption among large biopharmaceutical companies. AI CRM Adoption Could Be A Key Catalyst For Veeva Systems Stock
• Positive Sentiment: Analysts continue to raise their valuation expectations. Barclays lifted its price target to $375 from $360 and maintained an overweight rating, while Mizuho raised its target to $345 from $280. These moves signal confidence in Veeva’s growth outlook and AI-enabled product strategy. Barclays Price Target Increase Mizuho Price Target Increase
• Positive Sentiment: Investors are positioned for continued earnings growth. Analysts expect double-digit growth in the upcoming fiscal Q3 2027 report, while Veeva’s latest reported quarter exceeded consensus estimates for both revenue and earnings. What to Expect From Veeva Systems Q3 2027 Earnings Report
• Neutral Sentiment: Valuation is creating a debate. Veeva has recently generated strong momentum, but its high earnings multiple means the stock may be sensitive to guidance, margins and the pace of AI monetization in the upcoming results.
• Negative Sentiment: Recent gains may be prompting profit-taking. With shares near their 52-week high after substantial one- and three-month advances, investors may be locking in gains ahead of earnings, particularly if expectations for AI-driven growth are already reflected in the valuation. Veeva Systems Heads Into Q3 Results

Veeva Systems Profile

Veeva Systems Inc is a cloud software company that develops technology for the life sciences industry. Its customers include pharmaceutical, biotechnology, medical device and other healthcare companies that use Veeva's applications to manage commercial, clinical, regulatory, quality and operational processes.

The company's Veeva Vault platform provides cloud applications for areas such as clinical data management, electronic trial management, regulatory information, quality management, safety and content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.